Supramolecular assemblies of rifampicin and cationic bilayers: preparation, characterization and micobactericidal activity
Contribuinte(s) |
UNIVERSIDADE DE SÃO PAULO |
---|---|
Data(s) |
17/04/2012
17/04/2012
2011
|
Resumo |
Background: Cationic bilayers based on the inexpensive synthetic lipid dioctadecyldimethylammonium bromide (DODAB) have been useful as carriers for drug delivery, immunoadjuvants for vaccines and active antimicrobial agents. Methods: Rifampicin (RIF) or isoniazid (ISO) interacted with DODAB bilayer fragments (BF) or large vesicles (LV). Dispersions were evaluated by dynamic light-scattering for zeta-average diameter (Dz) and zeta-potential (zeta) analysis; dialysis for determination of drug entrapment efficiency; plating and CFU counting for determination of cell viability of Mycobacterium smegmatis or tuberculosis, minimal bactericidal concentration (MBC) and synergism index for DODAB/drug combinations. Results: DODAB alone killed micobacteria over a range of micromolar concentrations. RIF aggregates in water solution were solubilised by DODAB BF. RIF was incorporated in DODAB bilayers at high percentiles in contrast to the leaky behavior of ISO. Combination DODAB/RIF yielded MBCs of 2/2 and 4/0.007 mu g/mL against Mycobacterium smegmatis or Mycobacterium tuberculosis, respectively. Synergism indexes equal to 0.5 or 1.0, indicated synergism against the former and independent action, against the latter species. Conclusions: In vitro, DODAB acted effectively both as micobactericidal agent and carrier for rifampicin. The novel assemblies at reduced doses may become valuable against tuberculosis. Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) |
Identificador |
BMC BIOTECHNOLOGY, v.11, 2011 1472-6750 http://producao.usp.br/handle/BDPI/14814 10.1186/1472-6750-11-40 |
Idioma(s) |
eng |
Publicador |
BIOMED CENTRAL LTD |
Relação |
BMC Biotechnology |
Direitos |
openAccess Copyright BIOMED CENTRAL LTD |
Palavras-Chave | #LIPOSOMES #TUBERCULOSIS #DELIVERY #VESICLES #LIPIDS #DRUG #Biotechnology & Applied Microbiology |
Tipo |
article original article publishedVersion |